ストックスクリーナーアプリを入手
34.46
0.44%
0.15
プレマーケット:
34.96
0.50
+1.45%
前日終値:
$34.31
開ける：
$33.8
24時間の取引高:
341.58K
Relative Volume:
0.52
時価総額：
$1.57B
収益：
$1.18B
当期純損益:
$2.05M
株価収益率:
797.69
EPS:
0.0432
ネットキャッシュフロー:
$66.94M
1週間 パフォーマンス:
-1.80%
1か月 パフォーマンス:
-14.17%
6か月 パフォーマンス:
+11.59%
1年 パフォーマンス:
-1.94%
1日の値動き範囲:
$33.38
$34.76
1週間の範囲:
$32.19
$34.85
52週間の値動き範囲:
$22.66
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Compare OMCL vs VEEV, TEM, BTSG, HQY, WAY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
34.46 | 1.57B | 1.18B | 2.05M | 66.94M | 0.0432 |
VEEV
Veeva Systems Inc
|
179.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
48.83 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.31 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.10 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.03 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-04 | アップグレード | BofA Securities | Neutral → Buy |
| 2026-01-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-08-02 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 開始されました | Barclays | Underweight |
| 2023-11-03 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-11-03 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 繰り返されました | Wells Fargo | Underweight |
| 2023-08-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | アップグレード | The Benchmark Company | Hold → Buy |
| 2022-11-03 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 開始されました | BofA Securities | Buy |
| 2022-07-15 | 開始されました | SVB Leerink | Mkt Perform |
| 2021-12-06 | 再開されました | Wells Fargo | Overweight |
| 2021-06-09 | 開始されました | JP Morgan | Neutral |
| 2021-05-24 | 開始されました | BTIG Research | Buy |
| 2021-02-02 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 開始されました | Berenberg | Buy |
| 2020-12-03 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 開始されました | Stephens | Overweight |
| 2020-02-07 | 繰り返されました | Dougherty & Company | Buy |
| 2019-11-21 | 繰り返されました | Dougherty & Company | Buy |
| 2019-07-26 | アップグレード | Craig Hallum | Hold → Buy |
| 2019-03-07 | 繰り返されました | Dougherty & Company | Buy |
| 2018-06-29 | 再開されました | The Benchmark Company | Buy |
| 2017-09-05 | 繰り返されました | The Benchmark Company | Buy |
| 2017-07-28 | 繰り返されました | Dougherty & Company | Buy |
| 2017-04-21 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 開始されました | Dougherty & Company | Buy |
| 2016-12-06 | 繰り返されました | The Benchmark Company | Buy |
| 2016-07-07 | 繰り返されました | FBR Capital | Outperform |
| 2016-03-21 | 繰り返されました | Topeka Capital Markets | Buy |
| 2016-01-07 | 開始されました | The Benchmark Company | Buy |
| 2015-11-16 | 繰り返されました | Topeka Capital Markets | Buy |
| 2015-10-30 | 繰り返されました | FBR Capital | Outperform |
| 2015-09-28 | アップグレード | Sidoti | Neutral → Buy |
| 2015-07-31 | 繰り返されました | Topeka Capital Markets | Buy |
すべてを表示
Omnicell Inc (OMCL) 最新ニュース
Published on: 2026-03-25 03:49:16 - baoquankhu1.vn
Should You Continue to Hold OMCL Stock in Your Portfolio? - TradingView
Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Pharmaceutical Unit Dose Packaging Market Is Going to Boom | AptarGroup Inc. • Omnicell Inc. • Becton - openPR.com
OMCL PE Ratio & Valuation, Is OMCL Overvalued - Intellectia AI
Pharmacy Inventory Management Software Solutions And Cabinets - openPR.com
Update Recap: What chart patterns are forming on Omnicell Inc2026 Gainers & Verified Swing Trading Watchlist - baoquankhu1.vn
Medication Therapy Management Market Current Impact to Make Big Changes | CVS Health, Walgreens, Omnicell - openPR.com
Omnicell, Inc. (OMCL): A bull case theory - MSN
Omnicell (NASDAQ:OMCL) EVP Corey Manley Sells 7,405 Shares - MarketBeat
Omnicell (NASDAQ: OMCL) CEO RSUs vest; shares withheld for taxes - Stock Titan
Omnicell (OMCL) COO gains 37,409 shares; 8,456 withheld for taxes - Stock Titan
Omnicell (OMCL) EVP Manley reports PSU vesting, tax withholding and share sale - Stock Titan
Q4 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
OMCL (NASDAQ: OMCL) affiliate sales; 7,405 restricted shares vest on 03/15/2026 - Stock Titan
Benchmark reiterates Omnicell stock rating on product cycle outlook - Investing.com Australia
Benchmark reiterates Omnicell stock rating on product cycle outlook By Investing.com - Investing.com UK
Pier Capital LLC Reduces Stock Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell (NASDAQ:OMCL) Rating Increased to Hold at Zacks Research - MarketBeat
Telepharmacy Market Set to Witness Rapid Growth Through 2033 | - openPR.com
Omnicell (OMCL) to Participate in Benchmark's Virtual Meeting on March 11 - GuruFocus
How Omnicell Inc. (OMCL) Affects Rotational Strategy Timing - Stock Traders Daily
Dynamic Technology Lab Private Ltd Acquires 24,738 Shares of Omnicell, Inc. $OMCL - MarketBeat
What is Zacks Research's Estimate for Omnicell Q2 Earnings? - MarketBeat
Omnicell (OMCL) Analyst Maintains 'Buy' Rating, Raises Price Tar - GuruFocus
Quantbot Technologies LP Purchases Shares of 25,813 Omnicell, Inc. $OMCL - MarketBeat
Pharmacy Repackaging Systems Market Is Going to Boom Rapidly | - openPR.com
Intech Investment Management LLC Sells 135,679 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell Leans Into Healthcare IT As ANiGENT Deal Reshapes Growth Story - Sahm
Zacks Research Increases Earnings Estimates for Omnicell - MarketBeat
Aug Patterns: Is Omnicell Inc a play on infrastructure spendingGold Moves & High Conviction Investment Ideas - baoquankhu1.vn
How The Titan XT Cycle Is Rewriting The Omnicell (OMCL) Investment Story - Yahoo Finance
Will Strong Q4 Beat and Software Pivot Change Omnicell's (OMCL) Investment Narrative? - Yahoo Finance
JPMorgan Chase & Co. Sells Omnicell, Inc. $OMCL Shares - National Today
Omnicell, Inc. $OMCL Shares Sold by JPMorgan Chase & Co. - MarketBeat
Omnicell Stock Analysis: Strong Performance vs. Long-Term ConcernsNews and Statistics - IndexBox
OMCL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Omnicell, Inc. (OMCL) Stock Analysis: Strong Buy Ratings And Nearly 40% Upside Potential - DirectorsTalk Interviews
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead - Yahoo Finance
Vanguard Group Inc. Has $170.89 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Roubaix Capital LLC Purchases Shares of 76,383 Omnicell, Inc. $OMCL - MarketBeat
Assessing Omnicell (OMCL) Valuation As ANiGENT Deal Accelerates Shift To Software And Services - simplywall.st
What is Zacks Research's Estimate for Omnicell Q1 Earnings? - MarketBeat
Dividend Watch: Whats the fair value of Omnicell Inc stockEarnings Overview Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Should Omnicell’s Shift Toward Software and Services Require Action From Omnicell (OMCL) Investors? - simplywall.st
Omnicell, Inc. (OMCL): A Bull Case Theory - Finviz
OMCL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
What is Zacks Research's Estimate for Omnicell Q3 Earnings? - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Decoding Omnicell Inc (OMCL): A Strategic SWOT Insight - GuruFocus
(OMCL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Omnicell Inc (OMCL) 財務データ
収益
当期純利益
現金流量
EPS
3.50%
2.28%
大文字化:
|
ボリューム (24 時間):